HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation.

Abstract
PD-L1 expression in melanoma correlates with response to PD-1 pathway-blocking antibodies. Aberrant tumor-cell PD-L1 expression may be oncogene driven and/or induced by IFNγ. Melanomas express PD-L1 in association with tumor-infiltrating lymphocytes (TIL), but the potential contribution of the BRAF V600E mutation (BRAFmut) to induced PD-L1 expression has not been determined. Fifty-two archival melanocytic lesions were assessed for PD-L1 expression, TIL infiltration, and BRAFmut simultaneously. IFNγ-induced PD-L1 expression in cultured melanomas was assessed in parallel according to BRAF status. Melanocyte PD-L1 expression was observed in 40% of specimens, and BRAFmut was observed in 42% of specimens, but no significant concordance was found between these variables. Almost all melanocytes displaying PD-L1 expression were observed to be adjacent to TILs, irrespective of BRAF status. TIL(-) lesions were not more likely to be associated with BRAFmut, when compared with TIL(+) lesions. Baseline expression of PD-L1 by melanoma cell lines was virtually nil, regardless of BRAFmut status, and the intensity of IFN-induced PD-L1 expression in melanoma cell lines likewise did not correlate with BRAF mutational status. PD-L1 expression in melanocytic lesions does not correlate with the BRAFmut. Thus, distinct populations of melanoma patients will likely benefit from BRAF inhibitors versus PD-1 pathway blockade.
AuthorsNemanja Rodić, Robert A Anders, James R Eshleman, Ming-Tseh Lin, Haiying Xu, Jung H Kim, Katie Beierl, Shuming Chen, Brandon S Luber, Hao Wang, Suzanne L Topalian, Drew M Pardoll, Janis M Taube
JournalCancer immunology research (Cancer Immunol Res) Vol. 3 Issue 2 Pg. 110-5 (Feb 2015) ISSN: 2326-6074 [Electronic] United States
PMID25370533 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright©2014 American Association for Cancer Research.
Chemical References
  • B7-H1 Antigen
  • CD274 protein, human
  • Neoplasm Proteins
  • Interferon-gamma
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
Topics
  • B7-H1 Antigen (metabolism)
  • Humans
  • Interferon-gamma (immunology)
  • Lymphocytes, Tumor-Infiltrating (immunology)
  • Melanocytes (immunology)
  • Melanoma (genetics, immunology, secondary)
  • Mutation
  • Neoplasm Proteins (genetics, metabolism)
  • Nevus (genetics, immunology)
  • Proto-Oncogene Proteins B-raf (genetics)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: